NASDAQ: LYRA
Lyra Therapeutics Inc Earnings Dates, Reports, Calls

Lyra Therapeutics earnings were -$79.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LYRA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.5M, down 22.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LYRA reported annual earnings of -$93.4M, with 49.1% growth. The next LYRA earnings date is Aug 12, 2025.

LYRA earnings history

Current Revenue
$1.2M
Current Earnings
-$79.5M
Current Profit Margin
-6,711.4%

LYRA Return on Equity

Current Company
-474.4%
Current Industry
-60.2%
Current Market
31.3%
LYRA's Return on Equity (-474.4%)... subscribe to Premium to read more.
High Return on Equity Performance

LYRA undefined

Current Company
-107.5%
Current Industry
-2.5%
LYRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LYRA announces earnings.

LYRA undefined

Current Company
-177.28%
Current Industry
5.8%
LYRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LYRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LYRA-$79.04M-$79.53MN/A-$60.50
LPTX-$68.57M-$69.40MN/A-$1.70
BTAI-$24.24M-$40.06MN/A-$12.85
XTLB-$1.16M-$1.03MN/A-$0.20
BRTX-$11.78M-$12.10MN/A-$1.47

LYRA earnings dates

Next earnings date
Aug 12, 2025

Lyra Therapeutics Earnings Reports & History FAQ

What were Lyra Therapeutics's earnings last quarter?

On LYRA's earnings call on Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q1 2025 earnings per share (EPS) of -$6.50, up 62.86% year over year. Total LYRA earnings for the quarter were -$8.55 million. In the same quarter last year, Lyra Therapeutics's earnings per share (EPS) was -$17.50.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

When does Lyra Therapeutics report earnings?

The next LYRA earnings call is Invalid Date. Add LYRA to your watchlist to be reminded of Lyra Therapeutics's next earnings date.

Is Lyra Therapeutics profitable or losing money?

As of the last Lyra Therapeutics earnings report, Lyra Therapeutics is currently losing money. Lyra Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$79.53 million, a 15.47% increase year over year.

What was LYRA's earnings growth in the past year?

As of Lyra Therapeutics's earnings date in Invalid Date, Lyra Therapeutics's earnings has grown year over year. LYRA earnings in the past year totalled -$79.53 million.

What are Lyra Therapeutics's earnings expectations?

The current EPS estimate for Lyra Therapeutics's earnings report in Invalid Date is -$0.17.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.